Chinese english Germany Japanese Korea

Topotecan(Tpt)

Topotecan(Tpt) Struktur
139339-45-0
CAS-Nr.
139339-45-0
Englisch Name:
Topotecan(Tpt)
Synonyma:
Ro 24-7429;Tat,anti-inflammatory,antifibrotic,inhibit,Ro247429,Ro24-7429,RUNX1,Inhibitor,Apoptosis,Human immunodeficiency virus,HIV-1,anti-HIV,Ro24 7429,HIV
CBNumber:
CB41030572
Summenformel:
C14H13ClN4
Molgewicht:
272.73
MOL-Datei:
139339-45-0.mol
Request For Quotation

Topotecan(Tpt) Eigenschaften

storage temp. 
Store at -20°C
Aggregatzustand
Solid
Farbe
White to yellow

Sicherheit

Topotecan(Tpt) Chemische Eigenschaften,Einsatz,Produktion Methoden

Topotecan(Tpt) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Topotecan(Tpt) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 18)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
LEAPCHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 43348 58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. 17702719238 17702719238
 sales@sun-shinechem.com China 950 64
Hangzhou ChangCun Biotechnology Co., Ltd. 0571-; 13567100326
 158848739@qq.com China 108 50
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 4009686088
 3193328036@qq.com China 29786 68
Guangzhou Younan Technology Co., Ltd 020-020-82000279 18988968278
 sales@ubiochem.com China 4324 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369
3477467573@qq.com China 8618 58
InvivoChem 13549236410
 sales@invivochem.cn China 6747 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 23963 58
Suzhou Meishi Biotechnology Co., Ltd. 1173954148q
 meishipharma@126.com China 20035 58

139339-45-0()Verwandte Suche:

4-Fluorbenzonitril m-Cyanbenzoesure
  • Ro 24-7429
  • Tat,anti-inflammatory,antifibrotic,inhibit,Ro247429,Ro24-7429,RUNX1,Inhibitor,Apoptosis,Human immunodeficiency virus,HIV-1,anti-HIV,Ro24 7429,HIV
  • 139339-45-0
  • APIS
Copyright 2019 © ChemicalBook. All rights reserved